Drug Trial Radar · NCT07267221
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
Last checked: Nov 19, 2026Latest source record: Dec 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Dec 1, 2025
Primary completion
Jan 30, 2026
Study completion May 30, 2026
Sponsor
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.Industry
- Sponsor type
- Industry
- First posted
- Dec 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fed conditions.
Conditions
- Healthy Volunteers
Interventions
DWJ1622Drug
DWJ1622 (single oral dose) is administered in accordance with the study protocol.
DWC202313, DWC202314Drug
DWC202313, DWC202314(single oral dose) is administered in accordance with the study protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CmaxTime frame: At pre-dose (0 hours), and post-dose 1 to 72 hours.
- AUClastTime frame: Time Frame: At pre-dose (0 hours), and post-dose 1 to 72 hours.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
H Plus YANGJI Hospital
Seoul, Gwanak-gu, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.